ANNX FY 2019 Earnings — Annexon, Inc. Revenue & Financial Results | Market Cap Arena

ANNXAnnexon, Inc.

$706M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$33M

Net Income

-$37M

EPS (Diluted)

$-0.97

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$29M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$50M

Total Liabilities

$6M

Stockholders' Equity

$44M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$488,000	+100.0%
Operating Income	-$33M	-$19M	-69.8%
Net Income	-$37M	-$18M	-103.1%